Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
As of close of business last night, Cigna Group’s stock clocked out at $287.1, up 2.36% from its previous closing price of $280.47. In other words, the price has increased by $2.36 from its previous closing price. On the day, 1.41 million shares were traded. CI stock price reached its highest trading level at $287.38 during the session, while it also had its lowest trading level at $281.34.
Ratios:
To gain a deeper understanding of CI’s stock, we examine its different ratios. In the meantime, Its Debt-to-Equity ratio is 0.77 whereas as Long-Term Debt/Eq ratio is at 0.66.
On June 26, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $400.
On May 30, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $388.Robert W. Baird initiated its Outperform rating on May 30, 2024, with a $388 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 12 ’25 when Eder Noelle K bought 35,711 shares for $275.06 per share.
Palmer Eric P bought 610 shares of CI for $204,399 on May 09 ’25. On May 08 ’25, another insider, Palmer Eric P, who serves as the Former Officer of the company, bought 14,985 shares for $335.61 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CI now has a Market Capitalization of 76635029504 and an Enterprise Value of 102477053952. As of this moment, Cigna’s Price-to-Earnings (P/E) ratio for their current fiscal year is 15.68, and their Forward P/E ratio for the next fiscal year is 8.69. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.45. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.29 while its Price-to-Book (P/B) ratio in mrq is 1.90. Its current Enterprise Value per Revenue stands at 0.391 whereas that against EBITDA is 8.983.
Stock Price History:
The Beta on a monthly basis for CI is 0.48, which has changed by -0.14731216 over the last 52 weeks, in comparison to a change of 0.16657472 over the same period for the S&P500. Over the past 52 weeks, CI has reached a high of $370.83, while it has fallen to a 52-week low of $256.89. The 50-Day Moving Average of the stock is -5.13%, while the 200-Day Moving Average is calculated to be -7.06%.
Shares Statistics:
It appears that CI traded 1.91M shares on average per day over the past three months and 2478610 shares per day over the past ten days. A total of 266.60M shares are outstanding, with a floating share count of 262.90M. Insiders hold about 1.51% of the company’s shares, while institutions hold 88.87% stake in the company. Shares short for CI as of 1753920000 were 2453026 with a Short Ratio of 1.28, compared to 1751241600 on 2923086. Therefore, it implies a Short% of Shares Outstanding of 2453026 and a Short% of Float of 1.2200001.
Dividends & Splits
With its trailing 12-month dividend rate of 5.82, CI has a forward annual dividend rate of 5.82. Against a Trailing Annual Dividend Yield of 0.020750882The stock’s 5-year Average Dividend Yield is 1.34. The current Payout Ratio is 46.19% for CI, which recently paid a dividend on 2025-06-03 with an ex-dividend date of 2025-09-04. Stock splits for the company last occurred on 2007-06-05 when the company split stock in a 3:1 ratio.
Earnings Estimates
Cigna Group (CI) is presently subject to a detailed evaluation by 22.0 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is $8.03, with high estimates of $8.47 and low estimates of $7.48.
Analysts are recommending an EPS of between $29.86 and $29.23 for the fiscal current year, implying an average EPS of $29.66. EPS for the following year is $33.04, with 24.0 analysts recommending between $34.15 and $32.07.
Revenue Estimates
In the current quarter, 9 analysts expect revenue to total $67.19B. It ranges from a high estimate of $68.59B to a low estimate of $64.85B. As of the current estimate, Cigna Group’s year-ago sales were $63.69BFor the next quarter, 9 analysts are estimating revenue of $68.32B. There is a high estimate of $70.44B for the next quarter, whereas the lowest estimate is $65.6B.
A total of 17 analysts have provided revenue estimates for CI’s current fiscal year. The highest revenue estimate was $271.25B, while the lowest revenue estimate was $253.07B, resulting in an average revenue estimate of $262.65B. In the same quarter a year ago, actual revenue was $247.1BBased on 17 analysts’ estimates, the company’s revenue will be $272.74B in the next fiscal year. The high estimate is $289.14B and the low estimate is $261.94B.
